Literature DB >> 22341482

Depression, gender, and the treatment gap in Mexico.

Claudia Rafful1, María Elena Medina-Mora, Guilherme Borges, Corina Benjet, Ricardo Orozco.   

Abstract

BACKGROUND: Gender is associated to lifetime risk of mood disorders, women having the highest lifetime and 12-month prevalence. In Mexico one out of five individuals with any mood disorder receives treatment during the first year. We evaluate the ages at which women and men are more vulnerable for the first onset of a major depressive episode, the longest duration and greatest number of episodes, the areas of daily functioning most affected, and which variables predict whether or not a person receives any kind of treatment.
METHODS: The Mexican National Comorbidity Survey, as part of the World Mental Health Surveys Initiative, is based on a stratified, multistage area probability Mexican urban household sample aged 18 to 65 (n=5782). Wald X(2) tests were performed to evaluate gender and cohort differences; logistic regression models were performed to evaluate gender and cohort as treatment predictors.
RESULTS: The most vulnerable group is the cohort of 45-54 year-old women. Once a first episode occurs, there are no sex differences in terms of number or length of episodes. There is a gap in service use, especially among 18-29 year-old women; the oldest women are the most impaired. LIMITATIONS: Individuals from rural communities are not represented and there may have been recall bias due to the retrospective design.
CONCLUSIONS: Efforts should focus on factors related to the first onset episode and on early treatment programs to reduce the risk of subsequent episodes. Research and health resources should attend to the most vulnerable group, and the youngest women, who are in the reproductive age and have the largest treatment gap. Copyright Â
© 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22341482     DOI: 10.1016/j.jad.2011.12.040

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  9 in total

1.  Gender differences in depression in representative national samples: Meta-analyses of diagnoses and symptoms.

Authors:  Rachel H Salk; Janet S Hyde; Lyn Y Abramson
Journal:  Psychol Bull       Date:  2017-04-27       Impact factor: 17.737

2.  Factor structure of the Spanish version of the Patient Health Questionnaire-9 in Mexican women.

Authors:  Itziar Familiar; Eduardo Ortiz-Panozo; Brian Hall; Isabel Vieitez; Isabelle Romieu; Ruy Lopez-Ridaura; Martin Lajous
Journal:  Int J Methods Psychiatr Res       Date:  2014-12-19       Impact factor: 4.035

3.  Time and gender measurement invariance in the modified Calderon depression scale.

Authors:  Erika Arenas; Graciela Teruel; Pablo Gaitán-Rossi
Journal:  Health Qual Life Outcomes       Date:  2022-06-25       Impact factor: 3.077

4.  The role of gender and power dynamics in injection initiation events within intimate partnerships in the US-Mexico border region.

Authors:  Stephanie A Meyers; Laramie R Smith; Maria Luisa Mittal; Steffanie A Strathdee; Richard S Garfein; Andy Guise; Dan Werb; Claudia Rafful
Journal:  Cult Health Sex       Date:  2019-10-18

5.  Multidimensional analysis of health in Mexico: implementation of fuzzy sets.

Authors:  Lucio Flores-Payan; Diana Mercedes Hernández-Corona; Tonatiuh González-Heredia
Journal:  BMC Public Health       Date:  2021-05-19       Impact factor: 3.295

Review 6.  Factors associated with help-seeking behaviour among individuals with major depression: A systematic review.

Authors:  Julia Luise Magaard; Tharanya Seeralan; Holger Schulz; Anna Levke Brütt
Journal:  PLoS One       Date:  2017-05-11       Impact factor: 3.240

7.  Factors associated with health service utilisation for common mental disorders: a systematic review.

Authors:  Tessa Roberts; Georgina Miguel Esponda; Dzmitry Krupchanka; Rahul Shidhaye; Vikram Patel; Sujit Rathod
Journal:  BMC Psychiatry       Date:  2018-08-22       Impact factor: 3.630

8.  Old age and depression in Ghana: assessing and addressing diagnosis and treatment gaps.

Authors:  Peter Lloyd-Sherlock; Sutapa Agrawal; Mary Amoakoh-Coleman; Selasie Adom; Ebenezer Adjetey-Sorsey; Ilaria Rocco; Nadia Minicuci
Journal:  Glob Health Action       Date:  2019       Impact factor: 2.640

9.  Self-treatment and adverse reactions with herbal products for treating symptoms associated with anxiety and depression in adults from the central-western region of Mexico during the Covid-19 pandemic.

Authors:  Angel Josabad Alonso-Castro; Alan Joel Ruiz-Padilla; Miriam Ortiz-Cortes; Eleazar Carranza; Marco Antonio Ramírez-Morales; Raymundo Escutia-Gutiérrez; Yeniley Ruiz-Noa; Juan Ramon Zapata-Morales
Journal:  J Ethnopharmacol       Date:  2021-02-18       Impact factor: 5.195

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.